Skip to main content

Home/ Nutrition/ Group items matching ""renal cell"" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
1More

Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disea... - 0 views

  •  
    Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Kidd P. Altern Med Rev. 2003 Aug;8(3):223-46. Review. PMID: 12946237 Th1 pathways typically produce activation of cytotoxic T lymphocytes (Tc), NK cells, macrophages, and monocytes, all of which can attack cancer cells and generally defend against tumors. 55 IFN-gamma and other Th1 cytokines are typically lower in advanced cancer patients, while the Th2 marker IL-4 can be higher or unchanged.56 Nodules of non-small cell lung cancer freshly removed from patients expressed a marked imbalance toward Th2, as did biopsy samples from basal cell carcinoma.57 In prostate cancer patients IL-2 was low (Th1) and IL-10 high.58 IL-10 is a confirmed Th1-suppressive cytokine, and heightened IL-10 is a common factor in cancer.55 IL-10 has a variety of suppressive effects that include inhibiting Th1 cytokine production, down-regulating APC and NK cell function, and lowering overall T-cell proliferation.57 Especially under the influence of IL-4 (Th2), tumor cells apparently up-regulate IL-10 that suppresses nearby killer cells. Tumor-derived IL-10 has been documented in lymphoma, ovarian carcinoma, melanoma, neuroblastoma, and renal cell and colon carcinoma.57 IL-12 is another cytokine that can be up-regulated by Th1 activity and inhibited by Th2.59 A low IL-12/IL-10 ratio was found in cervical cancer patients.55 Recent clinical studies suggest elevated IL-10 is predictive of a poor prognosis. 57 With both IL-4 and IL-10 being proven inhibitors of Th1 and promoters of Th2 activity, the recognized capability of cancerous tissue to suppress immunity is readily rationalized.
1More

Fish, Vitamin D, and Flavonoids in Relation to Renal Cell Cancer Among Smokers -- Wilso... - 0 views

  •  
    Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Wilson RT, Wang J, Chinchilli V, Richie JP, Virtamo J, Moore LE, Albanes D. Am J Epidemiol. 2009 Sep 15;170(6):717-29. Epub 2009 Aug 3. PMID: 19651663 doi:10.1093/aje/kwp178 These results suggest that the flavonoid quercetin may prevent renal cell cancer among male smokers. The possible risk associated with fish intake warrants further investigation before conclusions may be drawn.
1More

Prostaglandins regulate acid-induced cell-mediated bone resorption -- Krieger et al. 27... - 0 views

  •  
    Krieger NS, Parker WR, Alexander KM, Bushinsky DA. Prostaglandins regulate acid-induced cell-mediated bone resorption. Am J Physiol Renal Physiol. 2000 Dec;279(6):F1077-82. Erratum in: Am J Physiol Renal Physiol 2001 Sep;281(3):section F following tabl
1More

Active specific immunotherapy of advanced renal-cell carcinoma. - [Eur Urol. 1978] - Pu... - 0 views

  •  
    Active specific immunotherapy of advanced renal-cell carcinoma. Tykkä H, Oravisto KJ, Lehtonen T, Sarna S, Tallberg T. Eur Urol. 1978;4(4):250-8. PMID: 668735
1More

Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaeno... - 0 views

  •  
    Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages. Kim YJ, Chung HY. J Med Food. 2007 Jun;10(2):225-31. PMID: 17651056 doi:10.1089/jmf.2006.092.
1More

Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implicatio... - 0 views

  •  
    Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides. Elmesery ME, Algayyar MM, Salem HA, Darweish MM, El-Mowafy AM. Cell Div. 2009 Apr 2;4(1):6. [Epub ahead of print] PMID: 19341447 doi:10.1186/1747-1028-4-6
1More

Advanced Renal Cell Carcinoma drug, Temsirolimus, gets fast track status from FDA - 0 views

  •  
    Wyeth Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted a new "fast track" designation for temsirolimus (CCI-779), an investigational mTOR kinase inhibitor, in the first-line treatment of poor-prognosis patients
1More

Kidney Cancer   | cancerlab.org - 1 views

  •  
    Being diagnosed with kidney cancer is scary and frightening news that can affect every aspect of one's life and future plans.
1 - 8 of 8
Showing 20 items per page